Literature DB >> 34699995

Do preoperative clinical and radiographic characteristics impact patient outcomes following one-level minimally invasive transforaminal lumbar interbody fusion based upon presenting symptoms?

Kyle W Morse1, Ram K Alluri1, Avani S Vaishnav1, Hikari Urakawa1, Jung Kee Mok2, Sohrab S Virk3, Evan D Sheha4, Sheeraz A Qureshi5.   

Abstract

BACKGROUND CONTEXT: Patients undergoing minimally invasive transforaminal lumbar interbody fusion (MI-TLIF) frequently present with lower extremity neurologic symptoms with or without associated lower back pain. While symptomatic improvement of leg and back pain has been reported, the resolution of back pain when it is a predominant presenting symptom remains underreported following MI-TLIF.
PURPOSE: The purpose of this study was to compare clinical outcomes at 1 year of patients undergoing MI-TLIF with lower extremity neurologic symptoms with and without a significant component of back pain. STUDY
DESIGN: A retrospective review of prospectively collected data from a single surgeon surgical database from 2017 to 2019 was performed. PATIENT SAMPLE: Fifty one patients undergoing MI-TLIF. OUTCOME MEASURES: Self-reported measures included the Oswestry Disability Index (ODI), Visual analog scale back pain (VAS-back), and VAS leg pain (VAS-leg).
METHODS: Patients were divided into two groups: Leg Pain Predominant (patients reported greater than 50% leg pain upon presentation) and Back Pain Predominant (patients reported 50% or greater back pain). Multivariate analysis was performed to determine differences between groups based upon any significantly baseline characteristics.
RESULTS: Preoperative demographic and radiographic outcomes were similar between the two groups. Both groups demonstrated significant improvement in ODI, VAS-Back and VAS-leg at 1-year postoperatively. On multivariate analysis, there were differences in ODI at 1-year, 1-year back pain, and 1-year leg pain between groups with those who initially presented with leg pain having a lower ODI, VAS Back, and VAS leg. Patients who presented with predominantly leg pain were more likely to meet minimal clinically important difference (MCID) criteria for ODI and VAS-back compared to those with predominantly back pain.
CONCLUSION: Following MI-TLIF, patients with lower extremity neurologic symptoms with and without a significant component of back pain have improvements in back pain, leg pain, and ODI regardless of their primary presenting pain complaint; however, patients who presented with predominantly leg pain were more likely to meet MCID criteria for improvement in their back pain and ODI score.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Back pain; Interbody fusion; Leg pain; Low Back Pain; MCID; Minimally invasive surgery; Postoperative back pain; Postoperative leg pain; Radicular Pain; TLIF

Mesh:

Year:  2021        PMID: 34699995      PMCID: PMC9178522          DOI: 10.1016/j.spinee.2021.10.013

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.297


  33 in total

1.  Pearls: Improving Upon Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Authors:  Sheeraz Qureshi
Journal:  Clin Orthop Relat Res       Date:  2019-03       Impact factor: 4.176

2.  Patients with predominantly back pain at the time of lumbar fusion for low-grade spondylolisthesis experience similar clinical improvement to patients with predominantly leg pain: mid-term results.

Authors:  Jannat M Khan; Garrett K Harada; Bryce A Basques; Michael T Nolte; Philip K Louie; Michael Iloanya; Konstantin Tchalukov; Mark Berkowitz; Peter Derman; Matthew Colman; Howard S An
Journal:  Spine J       Date:  2019-09-26       Impact factor: 4.166

3.  The effect of a radiographic solid fusion on clinical outcomes after minimally invasive transforaminal lumbar interbody fusion.

Authors:  Yung Park; Joong Won Ha; Yun Tae Lee; Na Young Sung
Journal:  Spine J       Date:  2011-03       Impact factor: 4.166

4.  Improvements in Back and Leg Pain Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Authors:  Dustin H Massel; Benjamin C Mayo; Ankur S Narain; Fady Y Hijji; Philip K Louie; Nathaniel W Jenkins; James M Parrish; Kern Singh
Journal:  Int J Spine Surg       Date:  2020-10

5.  Restoration of lumbar lordosis after minimally invasive transforaminal lumbar interbody fusion: a systematic review.

Authors:  Brandon B Carlson; Philip Saville; James Dowdell; Rie Goto; Avani Vaishnav; Catherine Himo Gang; Steven McAnany; Todd J Albert; Sheeraz Qureshi
Journal:  Spine J       Date:  2018-12-06       Impact factor: 4.166

6.  Substantial clinical benefit of minimally invasive lateral interbody fusion for degenerative spondylolisthesis.

Authors:  Kaveh Khajavi; Alessandria Shen; Anthony Hutchison
Journal:  Eur Spine J       Date:  2015-03-24       Impact factor: 3.134

7.  The reliability of determining "leg dominant pain".

Authors:  Eugene K Wai; Kelly Howse; J Whitcomb Pollock; Holly Dornan; Liisa Vexler; Simon Dagenais
Journal:  Spine J       Date:  2008-12-13       Impact factor: 4.166

8.  A Review of Techniques, Time Demand, Radiation Exposure, and Outcomes of Skin-anchored Intraoperative 3D Navigation in Minimally Invasive Lumbar Spinal Surgery.

Authors:  Avani S Vaishnav; Robert K Merrill; Harvinder Sandhu; Steven J McAnany; Sravisht Iyer; Catherine Himo Gang; Todd J Albert; Sheeraz A Qureshi
Journal:  Spine (Phila Pa 1976)       Date:  2020-04-15       Impact factor: 3.468

9.  Radiation Exposure in Minimally Invasive Transforaminal Lumbar Interbody Fusion: The Effect of the Learning Curve.

Authors:  Abhishek Kumar; Robert K Merrill; Samuel C Overley; Dante M Leven; Joshua J Meaike; Avani Vaishnav; Catherine Gang; Sheeraz A Qureshi
Journal:  Int J Spine Surg       Date:  2019-02-22

10.  Predictive Factors and Rates of Fusion in Minimally Invasive Transforaminal Lumbar Interbody Fusion Utilizing rhBMP-2 or Mesenchymal Stem Cells.

Authors:  Samuel C Overley; Steven J McAnany; Muhammad A Anwar; Robert K Merrill; Andrew Lovy; Javier Z Guzman; Sergey Zhadanov; Amish Doshi; Edward Rothenberg; Avani Vaishnav; Catherine Gang; Sheeraz A Qureshi
Journal:  Int J Spine Surg       Date:  2019-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.